High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for AIDS-related lymphoma: Long-term results of the Italian Cooperative Group on AIDS and Tumors (GICAT) study with analysis of prognostic factors

Blood

Volumn 114, Issue 7, 2009, Pages 1306-1313

  Re, Alessandro ^a   Michieli, Mariagrazia ^b   Casari, Salvatore ^c   Allione, Bernardino ^d   Cattaneo, Chiara ^a   Rupolo, Maurizio ^b   Spina, Michele ^b   Manuele, Rosa ^b   Vaccher, Emanuela ^b   Mazzucato, Mario ^b   Abbruzzese, Luciano ^b   Ferremi, Pierino ^a   Carosi, Giampiero ^c   Tirelli, Umberto ^b   Rossi, Giuseppe ^a  

^a SPEDALI CIVILI   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

^d C Arrigo Children's Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; BLEOMYCIN; CARMUSTINE; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; INTERFERON; MECLORETAMINE; MELPHALAN; MITOXANTRONE; OXALIPLATIN; PREDNISONE; PROCARBAZINE; PROTEINASE INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIBAVIRIN; RITUXIMAB; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; B CELL LYMPHOMA; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CYTOPENIA; DIARRHEA; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; HEPATITIS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; PYREXIA IDIOPATHICA; RECURRENT DISEASE; SALVAGE THERAPY; STEM CELL MOBILIZATION; STOMATITIS; SURVIVAL RATE; TREATMENT RESPONSE; AUTOTRANSPLANTATION; BLOOD; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FOLLOW UP; ITALY; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; ITALY; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SALVAGE THERAPY; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 70349328418     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-02-202762     Document Type: Article

References (36)

1. Levine AM. Acquired Immunodeficiency syndrome-related lymphoma: clinical aspects. Semin Oncol. 2000;27:442-453. (Pubitemid 30626443)
2. Tirelli U, Errante D, Dolcetti R, et al. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol. 1995;13:1758-1767.
3. Re A, Casari S, Cattaneo C, et al. Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma. Cancer. 2001;92:2739-2745. (Pubitemid 33091909)
4. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860. (Pubitemid 28135961)
5. Spina M, Jaeger U, Sparano JA, et al. Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials. Blood. 2005;105:1891-1897. (Pubitemid 40731769)
6. Spina M, Gabarre J, Rossi G, et al. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood. 2002;100:1984-1988. (Pubitemid 35001227)
7. Ribera JM, Oriol A, Morgades M, et al. Safety and efficacy of cyclophosphamide, Adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-call lymphoma: results of a phase II trial. Br J Haematol. 2007;140:411-419.
8. Kaplan LD, Lee JY, Ambinder RF, et al. Rituximab does not improve clinical outcome, in a randomized phase III trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin's lymphoma. AIDS Malignancies Consortium Trial 010. Blood. 2005;106:1538-1543.
9. Navarro H, Kaplan LD. AIDS-related lymphoproliferative disease. Blood. 2006;107:13-20.
10. Engels EA, Goedert JJ. Human immunodeficiency virus/acquired immunodeficiency syndrome and cancer: past, present, and future. J Natl Cancer Inst. 2002;97:407-409.
11. Lim ST, Karim R, Tulpule A, Nathwani BN, Levine AM. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol. 2005;23:8477-8482. (Pubitemid 46260244)
12. Levine AM, Tulpule A, Tessman D, et al. Mitoguazone therapy in patients with refractory or relapsed AIDS-related lymphoma: results from a multicenter phase II trial. J Clin Oncol. 1997;15:1094-1103. (Pubitemid 27106294)
13. Spina M, Vaccher E, Juzbasic S, et al. Human immunodeficiency virus-related non-Hodgkin lymphoma. Activity of infusional cyclophosphamide, doxorubicin, and etoposide as second-line chemotherapy in 40 patients. Cancer. 2001;92:200-206. (Pubitemid 32623058)
14. Bi J, Espina BM, Tulpule A, Boswell W, Levine AM. High-dose cytosine-arabinoside and cisplatin regimens as salvage therapy for refractory or relapsed AIDS-related non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr. 2001;28:416-421. (Pubitemid 34033191)
15. Philip T, Giglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995;333:1540-1545.
16. Linch DC, Winfield D, Goldstone AH, et al. Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease. Lancet. 1993;341:1051-1054.
17. Gabarre J, Azar N, Autran B, Katlama C, Leblonde V. High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet. 2000;355:1071-1072. (Pubitemid 30162812)
18. Krishnan A, Molina A, Zaia J, et al. Autologous stem cell transplantation for HIV-associated lymphoma. Blood. 2001;98:3857-3859.
19. Krishnan A, Molina A, Zaia J, et al. Durable remissions with autologous stem cell transplantation for high risk HIV-associated lymphomas. Blood. 2005;105:874-878. (Pubitemid 40070778)
20. Serrano D, Carriòn R, Balsalobre P, et al. HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation. Exp Hematol. 2005;33:487-494.
21. Gabarre J, Marcelin AG, Azar N, et al. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Haematologica. 2004;89:1100-1108. (Pubitemid 39295481)
22. Spitzer TR, Ambinder RF, Lee JY, et al. Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. Biol Blood Marrow Transplant. 2008;14:59-66.
23. Re A, Cattaneo C, Michieli MG, et al. High-dose therapy and autologous peripheral blood stem cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol. 2003;21:4423-4427. (Pubitemid 46621820)
24. Gribben JG, Goldstone AH, Linch DC, et al. Effectiveness of high-dose combination chemotherapy and autologous bone marrow transplantation for patients with non Hodgkin's lymphomas who are still responsive to conventional-dose therapy. J Clin Oncol. 1989;7:1621-1629.
25. Cheson BD, Horning SJ, Coiffier B, et al. Report of an international workshop to standardize response criteria for non-Hodgkin lymphoma. J Clin Oncol. 1999;17:1244-1253. (Pubitemid 29162950)
26. Balsalobre P, Diez-Martin JL, Re A, et al. Autologous stem-cell transplantation in patients with HIV-related lymphoma. J Clin Oncol. 2009;27:2192-2198.
27. Bower M, Stebbing J, Tuthill M, et al. Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma. Blood. 2008;111:3986-3990.
28. Resino S, Pèrez A, Seoane E, et al. Short communication: immune reconstitution after autologous peripheral blood stem cell transplantation in HIV-infected patients: might be better than expected? AIDS Res Hum Retroviruses. 2007;23:543-548.
29. Benicchi T, Ghidini C, Re A, et al. T-cell immune reconstitution after hematopoietic stem cell transplantation for HIV-associated lymphoma. Transplantation. 2006;81:673-682.
30. Diez-Martin JL, Balsalobre P, Re A, et al. Comparable survival between HIV positive and HIV negative Hodgkin's lymphoma and non-Hodgkin's lymphoma patients undergoing an autologous peripheral blood stem cell transplantation. A retrospective analysis of the EBMT Lymphoma Working Party [abstract]. Blood. 2007;110:Abstract 24.
31. Kewalramani T, Zelenetz AD, Nimer SD, et al. Rituximab and ICE as second line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood. 2004;103:3684-3688. (Pubitemid 38596282)
32. Schmitz N, Pfistner B, Sextro M, et al. Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haematopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial. Lancet. 2002;359:2065-2071. (Pubitemid 34680969)
33. Ferme C, Mounier N, Divine M, et al. Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial. J Clin Oncol. 2002;20:467-475. (Pubitemid 34072531)
34. Bannister WP, Cozzi-Lepri A, Clotet B, et al. Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the Euro-SIDA Study. J Acquir Immune Defic Syndr. 2008;48:324-333.
35. Re A, Tucci A, Casari S, et al. Treating lymphoma with curative intent in HIV positive patients after the advent of HAART: a comparative analysis with the HIV negative population [abstract]. Blood. 2008;112:Abstract 3603.
36. Simonelli C, Michieli M, Tedeschi R, et al. Hepatitis C virus infection does not prevent autologous bone marrow transplantation in HIV-related non-Hodgkin's lymphoma. AIDS. 2004;18:1859-1861. (Pubitemid 39179644)